Department of Cardiology, Oslo University Hospital Ullevaal

Current research focus

n/a

Research projects

Supervisor

• Aspirin non-responsiveness and Clopidogrel clinical Endepoint Trial (ASCET)
• Atherothrombotic risk markers in patients with diabete type 2 and coronary heart disease. Special emphasis on genetic regulation
• Atherosclerosis and the metabolic syndrome - role of inflammation and adipose tissue
• Glycoprotein 130 - A crosstalk between inflammation, Obesity and Atherosclerosis
• The role of metalloproteinases (MMPs) in atherosclerosis and various phases of coronary heart disease
• Influence of genetic polymorphisms on functional testing of clopidogrel non-responsiveness
• Exercise training in patients with coronary heart disease and type-2 diabetes
• Saxagliptin in atherosclerosis (SAXATH)

Collaborator

• Harmful effects on the heart by long term abuse of androgenic anabolic steroids, assessed by different cardiologic methods
• NORwegian Study on DIstrict treatment of ST-elevation Myocardial Infarction (NORDISTEMI)
• Safety and efficacy of levosimendan in patients with acute myocardial infarction complicated by symptomatic left ventricular failure
• Impaired glucose tolerance in patients with acute myocardial infarction.
• Postconditioning in ST-elevation myocardial infarction treated with primary PCI.
• Endothelial function and radical oxygen species formation in chronic heart failure
• A population based case-control study on atrial fibrillation. Importance of biomarkers
• NORCAST- Norwegian Cardiorespiratory Arrest Study
• Inflammation and electrical cardioversion for atrial fibrillation
• Inflammatory biomarkers and growth factors in patients with ST-elevation myocardial infarction